Trial Profile
Eicosapentaenoic acid/docosahexaenoic acid in elderly patient with mild-to-moderate depression
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2012
Price :
$35
*
At a glance
- Drugs Eicosapentaenoic acid/docosahexaenoic acid (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 18 Jan 2012 New trial record
- 01 Dec 2011 Results published in the European Archives of Psychiatry and Clinical Neuroscience.